Pages

Tuesday, August 1, 2017

Pharma Reviews: Doklam standoff fallout? Chinese co's $1.3 bn proposal to buy stake in Gland Pharma rejected

Shanghai Fosun Pharmaceutical's plan was to acquire stake in Gland Pharma through its subsidiaries outside India, namely Fosun Pharma Industrial ...
Read more: Doklam standoff fallout? Chinese co's $1.3 bn proposal to buy stake in Gland Pharma rejected